Milestone Scientific (MLSS) Competitors $0.58 -0.01 (-2.34%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLSS vs. INFU, KRMD, MGRM, CVRX, CV, TLSI, ELMD, BSGM, LNSR, and RCELShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include InfuSystem (INFU), KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), CVRx (CVRX), CapsoVision (CV), TriSalus Life Sciences (TLSI), Electromed (ELMD), Biosig Technologies (BSGM), LENSAR (LNSR), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Its Competitors InfuSystem KORU Medical Systems Monogram Orthopaedics CVRx CapsoVision TriSalus Life Sciences Electromed Biosig Technologies LENSAR Avita Medical InfuSystem (NYSE:INFU) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations. Does the media refer more to INFU or MLSS? In the previous week, Milestone Scientific had 2 more articles in the media than InfuSystem. MarketBeat recorded 2 mentions for Milestone Scientific and 0 mentions for InfuSystem. InfuSystem's average media sentiment score of 0.33 beat Milestone Scientific's score of -0.09 indicating that InfuSystem is being referred to more favorably in the media. Company Overall Sentiment InfuSystem Neutral Milestone Scientific Neutral Which has more risk & volatility, INFU or MLSS? InfuSystem has a beta of 1.81, suggesting that its share price is 81% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Do analysts rate INFU or MLSS? InfuSystem currently has a consensus target price of $12.50, indicating a potential upside of 29.67%. Milestone Scientific has a consensus target price of $1.25, indicating a potential upside of 114.04%. Given Milestone Scientific's higher probable upside, analysts clearly believe Milestone Scientific is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in INFU or MLSS? 71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 10.2% of InfuSystem shares are owned by company insiders. Comparatively, 24.8% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings & valuation, INFU or MLSS? InfuSystem has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$139.89M1.41$870K$0.2341.91Milestone Scientific$9.08M5.05-$6.93M-$0.09-6.49 Is INFU or MLSS more profitable? InfuSystem has a net margin of 1.12% compared to Milestone Scientific's net margin of -52.01%. InfuSystem's return on equity of 2.78% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Milestone Scientific -52.01%-60.26%-40.23% SummaryInfuSystem beats Milestone Scientific on 12 of the 17 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$45.88M$26.06M$5.75B$20.90BDividend YieldN/AN/A4.53%3.60%P/E Ratio-8.3412.7430.4428.33Price / Sales5.052.04391.6253.10Price / CashN/A12.8037.0323.77Price / Book5.312.079.005.19Net Income-$6.93M-$5.31M$3.26B$992.10M7 Day Performance0.83%1.21%1.00%-0.20%1 Month Performance-7.30%-2.61%4.23%1.30%1 Year Performance-41.49%-21.40%28.45%10.56% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific2.2597 of 5 stars$0.58-2.3%$1.25+114.0%-36.1%$45.88M$9.08M-8.3430Short Interest ↑Gap DownINFUInfuSystem3.4051 of 5 stars$9.53-1.0%$12.50+31.2%N/A$194.66M$139.89M158.86410KRMDKORU Medical Systems1.3698 of 5 stars$4.21+1.0%$4.63+9.9%+83.6%$192.80M$33.65M-46.7880MGRMMonogram Orthopaedics1.588 of 5 stars$5.32-0.2%$5.40+1.5%+76.2%$190.22M$370K-10.6428Earnings ReportShort Interest ↓CVRXCVRx2.597 of 5 stars$6.87-2.3%$14.00+103.8%-16.6%$183.85M$51.29M-3.27160CVCapsoVisionN/A$4.00+3.9%$5.50+37.5%N/A$178.43MN/A0.0090News CoverageEarnings ReportAnalyst RevisionTLSITriSalus Life Sciences3.0549 of 5 stars$4.86+6.8%$10.75+121.2%-10.2%$172.17M$29.43M-4.12106Analyst RevisionELMDElectromed1.7335 of 5 stars$19.69+4.0%$33.50+70.1%+33.2%$165.12M$61.44M26.25160News CoverageBSGMBiosig Technologies1.9499 of 5 stars$5.48+10.3%$10.00+82.5%+995.1%$156.15M$40K0.0050Earnings ReportGap DownHigh Trading VolumeLNSRLENSAR1.0414 of 5 stars$12.75+0.8%$15.00+17.6%+209.1%$150.98M$53.49M-3.03110Negative NewsRCELAvita Medical1.445 of 5 stars$5.55-1.4%$12.40+123.4%-47.1%$149.87M$64.25M-2.82130News Coverage Related Companies and Tools Related Companies InfuSystem Alternatives KORU Medical Systems Alternatives Monogram Orthopaedics Alternatives CVRx Alternatives CapsoVision Alternatives TriSalus Life Sciences Alternatives Electromed Alternatives Biosig Technologies Alternatives LENSAR Alternatives Avita Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access